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http://dx.doi.org/10.1016/j.jfma.201The appropriate management of hematology patients depends first on correct diagnoses.
Expert review is important in reaching accurate diagnoses. To improve diagnostic accuracy,
the Taiwan Society of Pathology and the Taiwan Division of the International Academy of Pa-
thology has been conducting an expert consultation program for general pathologists since
2001. As per this program, we have received a total of 395 cases (406 samples) for review.
We found that meaningful diagnostic discrepancies occurred frequently in hematopathology
reviews. Ambiguous or nondiagnostic original reports were the major causative factor for
the major discrepancy cases, which demonstrates that diagnostic uncertainty is a big problem
for referring pathologists. However, the World Health Organization lymphoma classification
may be poorly reproducible in countries where extensive use of an ancillary technique is not
used by general pathologists. This review is intended to report the misdiagnoses most
commonly seen in the hematopathology practice in Taiwan. Awareness of the easily misinter-
preted entities helps to achieve the right diagnosis and improve patient care.
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Table 1 Groups of causes in major discrepancy based on
review diagnoses.
Groups N Z 222 100 (%)
1. No submitted diagnosis/ambiguous
diagnosis
116 52
2. Subtype discrepancy 52 23
3. Malignancy revised as benign 32 14
4. Benign revised as malignancy 9 4
5. Lymphomas revised as nonlymphoma
tumors
11 5
6. Nonlymphoma tumors revised as
lymphomas
2 1
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Pathology consultation plays an important role in solving
diagnostic uncertainty and internal disagreements between
pathologists. It is divided into personal and institutional
consultation. The former denotes consultation that is sent
to an expert pathologist for review; the latter is generated
when a patient is transferred to a different institution,
where a pathologist needs to review the diagnosis.1
The appropriate management of hematological patients
depends primarily on correct diagnoses, because thera-
peutic strategies vary among different subtypes of hema-
tological diseases. However, hematology cases are
particularly complex, involving different organ systems and
displaying a variety of symptoms, and require interdisci-
plinary expertise. It has been found that there is a rela-
tively high rate of medical malpractice involving lymphoma
misdiagnosis.2 A centralized expert review as personal
consultation is therefore an important part of reaching an
accurate diagnosis. To improve diagnostic accuracy, the
Taiwan Society of Pathology and the Taiwan Division of the
International Academy of Pathology has conducted an
expert consultation program for general pathologists on a
nationwide basis since 2001. This consultation program was
voluntary for all practicing pathologists, who might submit
more difficult cases for consultation.3
Based on the data supplied and published by the Taiwan
Society of Pathology,3 from January 2003 to December
2011, there was a total of 3421 cases sent for consultation
in which hematopathology accounted for 620 cases (18.1%).
As a result of this program, we have received materials
involving a total of 395 patients (63.7%), contributing 406
clinical specimens during this period. All the cases were
sent for personal consultation to Dr. K.C. Chang in the
Department of Pathology, National Cheng Kung University
Hospital (Tainan, Taiwan). Professor I.J. Su reviewed
selected cases in this study. Patients transferred for
treatment or for second opinion (institutional consultation)
were not included. The vast majority of cases were sub-
mitted for consultation prior to when the local report was
issued. The materials received for review included hema-
toxylin and eosin stains and immunostained sections, clin-
ical information, and tentative diagnosis submitted by
referring pathologists. Further studies included immuno-
histochemical staining, in situ hybridization for Eps-
teineBarr virus-encoded RNAs (EBER),4 and the BIOMED-2
protocol-based B-cell or T-cell clonality tests.5
Discrepancies between submitted and review diagnoses
were scored as major discrepancies, minor discrepancies,
or insignificant (agreement), depending on whether the
divergence between diagnoses would alter clinical treat-
ment and case management according to the guidelines
recommended by the National Comprehensive Cancer
Network (NCCN).6 Major discrepancies are those that would
alter clinical management; minor discrepancies are those
that would not fundamentally alter management although a
different diagnosis was rendered. “Nondiagnostic reports”
were referred to as no diagnosis submitted by the referral
pathologist. “Ambiguous original reports” denoted a diag-
nosis that was not sufficiently specific to generate a
treatment recommendation, as dictated by NCCNguidelines (e.g., “lymphoma,” “lymphoproliferation,” or
multiple referrals that included both benign and malignant
diagnoses for the same case).
A higher discrepancy rate of hematopathology
consultation in Taiwan than in Western
countries
In our previous data, we found that pathology review
resulted in major, minor, and insignificant (or agreement)
diagnostic revisions in 222 (55%), 20 (5%), and 164 (40%) of
406 cases, respectively.7 There is a higher rate of major
discrepancies with many more ambiguous referral di-
agnoses in Taiwan compared with the rates in the United
States and the United Kingdom.6,8,9 The major diagnostic
revision rate was about 20e30% in institutional consultation
series in Western countries.6,8,9 In comparison, our personal
consultation series showed a much higher major revision
rate (55%, p < 0.001). This difference is attributable to a
different institutional versus personal consultation format.
In our consultation program, the referring pathologists
likely deferred their diagnoses or listed multiple diagnoses
in the knowledge that the case would be reassessed.
Another contributing factor is the differential calculation
criteria for discrepancies in T-cell lymphomas. The newest
NCCN guideline has added different management modal-
ities for different T-cell lymphoma subtypes.10 Accordingly,
we regarded the revision between those different lym-
phoma subtypes as major discrepancies, but they were not
defined as such by Matasar et al6 and Proctor et al.9
Concomitantly, there was a relatively higher frequency of
T-cell lymphoma in Taiwan,11 which increased the diver-
gence rate between diagnoses.12
Ambiguous or nondiagnostic original reports
predominate in the major discrepancy
category
For further analysis of error causes, we further divided the
cases in the major discrepancy category into six groups
(Table 1). Group 1, comprising the majority of cases
(nZ 116, 52.3%), was composed of nondiagnostic (nZ 18)
or ambiguous original reports (n Z 98). In this group, the
740 C. Chan et al.more common lymphoma types based on review diagnoses
were diffuse large B-cell lymphoma (DLBCL; 17%), marginal
zone lymphoma, nodal and MALT (mucosa-associated
lymphoid tissue) types (11%), and follicular lymphoma
(11%). Group 2 included subtype revisions among hemato-
logic cancers (n Z 52, 23.4%), in which the more common
entities were DLBCL (19%), Hodgkin lymphoma (14%), and
plasmacytoma/myeloma (12%). Group 3 consisted of cases
involving change from malignant to benign lesions (nZ 32,
14.4%), where the more common benign mimickers for
lymphomas were florid lymphoid hyperplasia (n Z 15) and
lymphocytic panniculitis (n Z 4). Group 4 comprised nine
cases with changes from benign diseases to lymphomas.
The 11 cases of nonhematologic tumors (group 5) were
composed of entities that either mimicked lymphomas
(nZ 5) or true histiocytic/dendritic cell neoplasms (nZ 6).
The two cases in group 6 were Hodgkin lymphoma and pe-
ripheral T-cell lymphoma, NOS (not otherwise specified).
In the 222 major discrepancies shown in Table 1, there
were only 16 cases (7.2%) in which the diagnoses were
corrected by morphologic evaluations alone. In the
remaining cases (n Z 206, 92.8%), the corrected diagnoses
required additional studies, including immunohistochem-
ical stains (n Z 205) and molecular studies for B-cell or T-
cell clonality (n Z 5) with both methods performed in four
cases. One major concern is that the change in a pathologic
diagnosis may have a detrimental impact on the patient’s
health. Fortunately, in the vast majority of cases with
diagnostic discrepancies, the referral pathologists were
informed of the revisions prior to when the original reports
had been issued. From this study, the sobering thought and
clinical significance are that the World Health Organization
approach has made the lymphoma classification really
poorly reproducibledat least in countries where an
extensive use of ancillary technique is not used by general
pathologists. Thus, in these areas, the setup of hema-
topathology consultation centers or review systems is
important to minimize interpretation errors.
Differences in subtype frequency between
consultation series and hospital-based
lymphoma populations
From our previous studies, we found differences in subtype
frequency between consultation series and hospital-based
lymphoma populations, which denoted consecutive lym-
phoma cases diagnosed and/or treated in our hospital.11 In
the consultation population, there were a total of 259
lymphoma cases that comprised 187 cases (72%) of B-cell
and Hodgkin lymphomas and 72 cases (28%) of T- and NK-
cell lymphomas (Table 2, left panel).11 Compared with
our hospital-based lymphoma population (Table 2, right
panel),11 follicular lymphoma, Hodgkin lymphoma, and
angioimmunoblastic T-cell lymphoma showed a higher fre-
quency in the consultation lymphoma subtypes, but DLBCL
and mycosis fungoides had a lower frequency. The higher
frequency of the three lymphoma subtypes may have
resulted from the higher difficulty in morphological recog-
nition or, alternatively, from a genuine increased incidence
in Taiwan.13 By contrast, the lower frequency of DLBCL in
consultation series may reflect its higher incidence andeasier recognition. In general, DLBCL had the highest
concordant review rate.8 The lower representation of
mycosis fungoides on consultation is likely attributable to
an institutional bias; in our dermatology/dermatopathology
department, the biopsy of skin lesions is relatively popular
and active, perhaps accounting for the higher detection
rate of mycosis fungoides.11Differential diagnosis between carcinoma and
lymphoma
The differentiation of carcinoma from lymphoma has a
large impact on clinical management,14 and, fortunately,
discriminating between the two is usually not a problem.
However, this may sometimes be complicated by the
emergence of lymphomas with spindle, signet ring, rosette,
or nest-forming tumor cells,15,16 or aberrant immunophe-
notyping of CD45/CD3/CD20/CKþ/EMAþ, or both.17,18
Anaplastic large cell lymphoma is a well-known example
of lymphoma displaying carcinoma characteristics.19
Anaplastic lymphoma kinase (ALK) detection may not be
helpful because it is negative in some anaplastic large cell
lymphomas and positive in some carcinomas, especially
those of pulmonary origin.20,21 In the more complex cases,
T-cell or B-cell clonality and specific genetic studies for
genetic signatures may be useful.17,18,22 In addition, the
importance of a patient’s clinical history and communica-
tion between pathologists and oncologists cannot be over-
emphasized. For example, an initial manifestation of
systemic lymphadenopathy with hepatosplenomegaly
would favor a diagnosis of lymphoma over carcinoma.18,23
Fig. 1 illustrates a case of T-cell lymphoma mimicking
undifferentiated carcinoma. A 69-year-old male suffered
from systemic lymphadenopathy and right oropharyngeal
enlargement for 3 weeks. Image study also revealed mul-
tiple hepatic and splenic masses. A tonsillar biopsy showed
dense infiltration of round tumor cells in single or small
nests with a starry sky appearance focally (Fig. 1A). Tumor
cells have abundant pale cytoplasm, round nuclei, rela-
tively fine chromatin, and one or several prominent nucleoli
(Fig. 1B). Immunohistochemically, the tumor cells were
negative for CK, LCA, CD2, CD3, CD20, EMA, CD21, CD30,
CD79a, bcl-2, CD123, CD138, bcl-6, PAX-5, MUM-1, CD61,
CD34, CD25, cyclin D1, CD117, p63, Melan-A, SMA, myoge-
nin, MPO, CD31, lambda, kappa, CD23, ALK-1, TdT, CD38,
CD68, CD10, CD1a, S-100, CD56, CD45RO, or HHV-8. EBER in
situ hybridization was also negative. The only positive
marker was CD43 (Fig. 1C). Together with the clinical his-
tory of systemic lymphadenopathy with involvement of
liver and spleen, malignant lymphoma, probably of T-cell
lineage was considered, although molecular studies for T-
cell and B-cell clonality were negative.Differential diagnosis between benign and
malignant lymphoid lesions
The differentiation between benign and malignant
lymphoid lesions is critical and sometimes difficult. Table 3
lists the benign mimickers for lymphomas where florid
lymphoid hyperplasia with marginal zone hyperplasia and
Table 2 Comparison of lymphoma subtypes between hospital- and consultation-based populations.
2003e2011 Consultation-based lymphoma distribution 1995e1999 Hospital-based lymphoma distribution11
B-cell lymphoma (72%) N Z 187 100 (%) B-cell lymphoma (61%) N Z 107 100 (%) p (c2 testa)
Diffuse large B-cell lymphoma 43 23 Diffuse large B-cell lymphoma 58 54 <0.001
Marginal zone lymphoma 37 20 Marginal zone lymphoma 19 18 0.670
Follicular lymphoma 29 16 Follicular lymphoma 8 7 0.046
Hodgkin lymphoma 28 15 Hodgkin lymphoma 7 7 0.032
Plasmacytoma/myeloma 8 4 Not listed d d d
Small lymphocytic
lymphoma/leukemia
7 4 Small lymphocytic lymphoma 6 6 0.454
Immunodeficiency-associated
LPD/PTLD
8 4 Not listed d d d
Lymphoplasmacytic lymphoma 6 3 Lymphoplasmacytic lymphoma 2 2 0.497
Burkitt lymphoma 4 2 Burkitt lymphoma 3 3 0.719
Mantle cell lymphoma 4 2 Mantle cell lymphoma 3 3 0.719
B-lymphoblastic lymphoma/leukemia 3 2 B-lymphoblastic lymphoma 1 1 0.633
Other B-cell lymphomas 10 5 Not listed d d d
T-cell lymphoma (28%) N Z 72 100 (%) T-cell lymphoma (39%) N Z 68 100 (%) p (c2 testa)
Anaplastic large cell lymphoma
(ALCL)
16 22 Anaplastic large cell lymphoma 8 12 0.101
Angioimmunoblastic T-cell
lymphoma
15 21 Angioimmunoblastic T-cell
lymphoma
4 6 0.010
Peripheral T-cell lymphoma, NOS 11 15 Peripheral T-cell lymphoma, NOS 12 18 0.705
NK/T-cell lymphoma 11 15 NK/T cell lymphoma nasal and
nasal-type
13 19 0.547
Cutaneous mycosis fungoides 4 6 Mycosis fungoides 13 19 0.014
Cutaneous ALCL/lymphomatoid
papulosis
5 7 Cutaneous ALCL/lymphomatoid
papulosis
5 7 0.925
Cutaneous small-medium
CD4þ TCL
1 1 Not listed d d d
Enteropathy-associated T-cell
lymphoma
3 4 Enteropathy-type T-cell lymphoma 1 1 0.339
T-lymphoblastic
lymphoma/leukemia
2 3 T-lymphoblastic lymphoma/leukemia 7 10 0.070
Adult T-cell leukemia/lymphoma 1 1 Adult T-cell leukemia/lymphoma 1 1 0.968
Other T-cell lymphomas 3 4 Subcutaneous panniculitis-like TCL 4 6 0.641
LPD/PTLDZ lymphoproliferative disorders/posttransplant lymphoproliferative disorders; NOSZ not otherwise specified; TCLZ T-cell
lymphoma.
a Fisher exact test when number less than 5.
Figure 1 Large T-cell lymphoma mimicking undifferentiated carcinoma. (A) Section shows tonsillar tissue with dense infiltration
of round tumor cells that occasionally involves mucosa in single cells or small nests and show a starry sky appearance focally (H&E,
40). (B) Tumor cells have abundant pale cytoplasm, round nuclei, relatively fine chromatin, and one or several prominent nucleoli
(H&E, 400). (C) Immunohistochemically, the only positive marker is CD43 (CD43, 200). H&E Z hematoxylin and eosin.
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Table 3 List of benign mimickers for lymphomas based on review diagnoses.
Case Age (y) Sex Organ Submitted diagnosis Review diagnosis
1 21 M Lymph node Anaplastic large cell lymphoma Lymphoid hyperplasia with monocytoid B-cell
hyperplasia
2 20 F Lymph node Anaplastic large cell lymphoma Lupus lymphadenopathy
3 48 F Lymph node Angioimmunoblastic T-cell lymphoma Lymphoid hyperplasiaa
4 31 F Lymph node Angioimmunoblastic T-cell lymphoma Lymphoid hyperplasia
5 52 F Lymph node Diffuse large B-cell lymphoma Atypical marginal zone hyperplasiab
6 35 M Gall bladder Diffuse large B-cell lymphoma or MALT lymphoma Chronic follicular cholecystitis with atypical large
B-cell hyperplasia
7 78 F Lymph node Diffuse large B-cell lymphoma or anaplastic large
Cell lymphoma
EBV-associated lymphoid hyperplasia
8 25 M Lymph node Diffuse large B-cell lymphoma, T-cell-rich variant Dermatopathic lymphadenopathy with immunoblastic
hyperplasia
9 40 M Mediastinum ErdheimeChester disease Fibrosis and xanthogranulomas, post-treated
10 34 M Lymph node Follicular lymphoma Lymphoid hyperplasia
11 54 M Lymph node Follicular lymphoma Lymphoid hyperplasia
12 58 F Cervix uteri Follicular lymphoma or MALT lymphoma Endocervical polyp with follicular cervicitis
13 83 F Spleen Histiocytic sarcoma Passive congestion with histiocytosis and extramedullary
hemopoiesis
14 67 M Lymph node Hodgkin lymphoma Castleman disease, stromal-rich variant
15 34 F Lymph node Hodgkin lymphoma Kikuchi disease
16 30 F Lymph node Hodgkin lymphoma Lymphoid hyperplasia
17 12 M Nasopharynx Hodgkin lymphoma or T-cell-rich B-cell lymphoma Infectious mononucleosis
18 35 M Lymph node Hodgkin lymphoma, mixed cellularity Lymphoid hyperplasia with monocytoid B-cell
hyperplasia
19 50 M Stomach MALT lymphoma, residual No residual lymphoma
20 66 M Stomach MALT lymphoma Follicular gastritisb
21 36 M Submandibular gland MALT lymphoma Lymphoepithelial sialadenitis with marginal zone
hyperplasia
22 23 M Stomach MALT lymphoma Ulcer with follicular gastritis
23 36 F Stomach MALT lymphoma Ulcer with H. pylori infection
24 38 F Skin Mycosis fungoides Atypical T-cell hyperplasia (pseudo-T-cell lymphoma)a
25 66 M Skin Mycosis fungoides or lymphomatoid papulosis Erythema multiforme
26 90 M Nasopharynx Nasal NK/T-cell lymphoma Atypical lymphoid hyperplasiac
27 81 M Lymph node Peripheral T-cell lymphoma EBV-associated lymphoid hyperplasia
28 46 M Lymph node Peripheral T-cell lymphoma Lymphoid hyperplasia with immunoblastic hyperplasia
29 51 M Skin Subcutaneous panniculitis-like T-cell lymphoma Panniculitis with foreign body reaction
30 28 F Skin Subcutaneous panniculitis-like T-cell lymphoma Lymphocytic lobular panniculitisd
31 27 F Skin Subcutaneous panniculitis-like T-cell lymphoma Lymphocytic lobular panniculitisd
32 33 F Skin Subcutaneous panniculitis-like T-cell lymphoma Lymphocytic lobular panniculitis
EBV Z EpsteineBarr virus; MALT lymphoma Z mucosa-associated lymphoid tissue type lymphoma.
a T-cell clonality negative.
b B-cell clonality negative.
c EBER (EBV-encoded small RNA) negative.
d Lupus panniculitis was suspected.
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Figure 2 Drug-related lymphadenopathy/hypersensitivity mimicking angioimmunoblastic T-cell lymphoma. A 70-year-old male
presented with fever and diffuse lymph node enlargement over neck, axilla, mediastinum, and inguinal areas for 1 month. (A) A
neck lymph node biopsy shows total effacement of nodal architecture by a diffuse lymphoid infiltrate with multiple foci of pale
zones and vascular hyperplasia (H&E, 40). (B) Many of the hyperplastic blood vessels have morphology of high-endothelial venules
with an arborizing pattern (H&E, 100). (C) The infiltrate is composed of a spectrum of small to large lymphoid cells with mild
atypia (arrows) and a brisk mitotic activity (arrowheads) (H&E, 400). Some immunoblasts are noted. The above features are very
reminiscent of angioimmunoblastic T-cell lymphoma. (D) This lesion is positive for T-cell receptor gene rearrangements by the
BIOMED-2 protocol. H&E Z hematoxylin and eosin; M Z markers; Y, A, B, C Z PCR tubes.
Hematopathology consultation 743other atypical changes have been frequently mis-
interpreted as follicular lymphoma,24 marginal zone lym-
phoma (nodal or MALT type),25 Hodgkin’s lymphoma,16 or
angioimmunoblastic T-cell lymphoma,26 and lymphocyticTable 4 List of cases with diagnoses changed from benign lesio
Case Age (y) Sex Organ Submitted diagnosi
1 84 M Lymph node Angiolymphoid hyp
eosinophilia
2 77 F Lymph node Lymphoid hyperpla
3 60 F Lymph node Atypical B-cell hyp
4 60 F Lymph node Granulomatous infl
5 57 M Skin Interface dermatiti
multiforme?
6 62 M Lymph node Reactive change
7 54 F Larynx Atypical lymphoid
8 53 F Liver Autoimmune hepat
hepatitis
9 83 F Bone marrow Hypercellular marr
EBV Z EpsteineBarr virus; MALT lymphoma Z mucosa-associated lymlobular panniculitis has imitated subcutaneous panniculitis-
like T-cell lymphoma.26 Drug-related lymphadenopathy/
hypersensitivity may mimic angioimmunoblastic T-cell
lymphoma very closely.27 We had encountered an elderlyns to lymphomas.
s Review diagnosis
erplasia with Angioimmunoblastic T-cell lymphoma
sia Angioimmunoblastic T-cell lymphoma
erplasia Diffuse large B-cell lymphoma
ammation EBVþ B-cell lymphoma of the elderly,
polymorphic type
s. Erythema Lymphomatoid papulosis
Lymphoplasmacytic lymphoma
hyperplasia MALT lymphoma
itis or IgG4-related Multiple myeloma
ow T-cell lymphoma involvement
phoid tissue type lymphoma.
Figure 3 Morphologic features of lymphoplasmacytic lymphoma. (AeB) This lymph node involved by lymphoplasmacytic lym-
phoma shows (A) interfollicular infiltration with a residual germinal center, and (B) retention of normal architecture with dilated
sinuses (arrows), which may be reminiscent of reactive lymphadenopathy (H&E, 100). (CeF) The characteristic features (H&E)
include increased infiltration of mast cells (arrows in C, 400), plasma cells (arrowheads in C), hemosiderin deposition (arrows in D,
400), and monotypic kappa light chain restriction [(E) kappa, 40; (F) lambda, 40]. H&E Z hematoxylin and eosin.
744 C. Chan et al.patient who presented with fever and systemic lymphade-
nopathy with morphology reminiscent of angioimmuno-
blastic T-cell lymphoma. T-cell receptor gene
rearrangements were also positive (Fig. 2). The patient was
later prepared for chemotherapy, but a final assessment
found that his systemic lesions had disappeared. Upon
taking his medical history, we learned that the patient had
been taking a Chinese herbal medication the previous
month. Clinical correlation, peripheral eosinophilia, and
identification of necrotic foci help to establish the diag-
nosis.27 Other lesions that have been misdiagnosed as
lymphoma include infectious mononucleosis,24 Kikuchi dis-
ease,28 EpsteineBarr virus (EBV)-associated lymphoid hy-
perplasia/reactivation,26 lupus lymphadenitis,28 and
stromal-rich hyaline vascular Castleman disease.29 In pa-
tients with adult-onset immunodeficiency syndrome,30
systemic mycobacterial lymphadenopathy would also
masquerade as peripheral T-cell lymphoma, NOS, or
angioimmunoblastic T-cell lymphoma.31 Microscopically,the lymph node is usually effaced with a dense T-cell
infiltrate and some poorly formed granulomas. The clue is
the presence of neutrophilic aggregates, which warrant the
routine acid-fast staining.31
By contrast, fewer lymphomas have been missed:
angioimmunoblastic T-cell lymphoma,32 DLBCL variants,16
lymphoplasmacytic lymphoma,26 lymphomatoid pap-
ulosis,33 and MALT lymphoma34 (Table 4). The lymph nodes
involved by lymphoplasmacytic lymphoma may show
interfollicular infiltration with prominent residual germinal
centers (Fig. 3A), and retention of normal architecture with
dilated sinuses (Fig. 3B), which are very reminiscent of
reactive lymphadenopathy.34 Increased mast cells, hemo-
siderin deposition, and plasma cells with Dutcher bodies
and light chain restriction are typical features (Fig. 3Ce3F).
In addition, the clinical features frequently show immuno-
globulin (Ig)M monoclonal gammopathy.
Age-related EBV-associated lymphoproliferative disor-
ders (LPDs) were initially defined as an EBVþ clonal B-cell
Figure 4 Senile EBVþ diffuse large B-cell lymphoma is the malignant end of age-related EBV-associated lymphoproliferative
disorders. (A) Low-power field shows gastric tissue with full-layer infiltration of large tumor cells arranged in diffuse and focally
nodular patterns (H&E, 40). (B) Tumor necrosis with perforation and angiocentricity is noted (H&E, 100). (C) The tumor cells are
large with moderate amount of cytoplasm, vesicular nuclei and prominent nucleoli (H&E, 400). There are many tumor giant cells
with a Hodgkin-like appearance (inset in C, 400). Immunohistochemically, the tumor cells are positive for LCA, CD20 (D, 400),
bcl-2 and MUM-1 but negative for bcl-6 or CD10. EBER in situ hybridization shows positivity in both smaller and Hodgkin-like tumor
cells (E, 100). EBER Z EpsteineBarr virus-encoded RNA; EBV Z EpsteineBarr virus-positive; H&E Z hematoxylin and eosin.
Hematopathology consultation 745lymphoid proliferation or DLBCL, which occurs in patients
older than 40 years without any immunodeficiency or un-
derlying lymphoma.34,35 Later, Dojcinov et al36 expanded
the disease spectrum and classified these disorders into
four pathologic categories: (1) reactive lymphoid hyper-
plasia, (2) polymorphic extranodal LPD, (3) polymorphic
nodal LPD, and (4) DLBCL. They also included EBVþTable 5 Nonhematologic tumors mimicking lymphomas or
histiocytic/dendritic cell neoplasms.
Diagnosis No. (N Z 11)
Lymphoma-like 5
Poorly differentiated/undifferentiated
carcinoma
3
Epithelioid angiosarcoma 1
Rhabdomyosarcoma 1
Histiocytic/dendritic cell neoplasm-like 6
Cellular neurothekeoma 2
Schwannoma 1
Malignant fibrous histiocytoma 1
Inflammatory myofibroblastic tumor 1
Tenosynovial giant cell tumor 1mucocutaneous ulcers in the polymorphic extranodal LPD
category.37 In contrast to poor outcomes for the latter two
categories, reactive hyperplasia and polymorphic extra-
nodal LPD generally have good prognoses.36 These four
pathology categories are excellent predictors of outcome;
however, their classification and differentiation from other
entities, such as EBVþ Hodgkin lymphoma, can be prob-
lematic. In addition to prudent morphology recognition and
a thorough clinical history, EBER in situ hybridization and
polymerase chain reaction for B-cell clonality may be use-
ful.36 We would suggest routine staining of EBER in situ
hybridization for cases that show the characteristic fea-
tures of a polymorphic infiltrate composed of small and
large lymphocytes with some Hodgkin and ReedeSternberg-
like cells, geographic necrosis, and angiocentricity. Fig. 4
illustrates a case of EBVþ senile DLBCL. This 76-year-old
female had a sudden onset of abdominal pain. Right neck
lymphadenopathy with body weight loss (6 kg) for 4 months
was noted. A chest X-ray showed internal organ perfora-
tion. An emergent exploratory laparotomy showed a gastric
tumor (7 cm  5 cm  2 cm) with perforation, and subtotal
gastrectomy was done. Unfortunately, she died of gastro-
intestinal bleeding and infection 31 days after the
operation.
Figure 5 A case of colonic schwannoma has been misinterpreted as interdigitating dendritic cell sarcoma. (A) Section shows a
well-defined, nonencapsulated spindle cell tumor involving in the colon wall (H&E, 40). (B) Intermixed lymphoplasmacytic cells
are present within and around the tumor imparting a feature of lymphoid cuffing in which germinal center formation is discerned
(lower right and left) (H&E, 40). (CeD) The spindle cells (H&E) are bundled as short fascicles (C, 100), and bland-looking with
elongated nuclei, pointed ends and one delicate nucleolus (D, 400). Mitotic figure is negligible. H&E Z hematoxylin and eosin.
746 C. Chan et al.IgG4-related lymphadenopathy is a recently defined
entity and shows a broad spectrum of morphology.38,39
Thus, differential diagnoses may include luetic lymphade-
nitis, Castleman disease (hyaline-vascular or plasma-cell
type), inflammatory pseudotumor, and autoimmune-
related lymphadenopathy.38 The suggestive morphology
includes a dense lymphoplasmacytic infiltrate, storiform-
type fibrosis, and obliterative phlebitis.40 A combination
of clinical and laboratory features is mandatory to make
the diagnosis because increased IgG4-positive plasma cells
can also be found in many other inflammatory and immune
diseases.40,41 In cases with no clinical data available, a
descriptive term such as lymphoplasmacytic hyperplasia
with increased IgG4þ cells accompanied by a note for
clinical survey may be appropriate.42 Again, clinical infor-
mation, IgG4 staining, and a high level of caution are key
for a correct diagnosis.
Differential diagnosis between hematologic
and nonhematologic stromal cell tumors
Finally, the difference between hematologic and non-
hematologic stromal cell tumors may be challenging and
obscured by the divergent histiocytic/dendritic cell origins;
macrophages and antigen-presenting dendritic cells are
derived from bone marrow progenitor cells, whereas
follicular dendritic cells are believed to be derived from
mesenchymal stem cells.34 As shown here, true histiocytic
and dendritic cell neoplasms43 have been confused with
cellular neurothekeoma, schwannoma, malignant fibroushistiocytoma, inflammatory myofibroblastic tumors, and
tenosynovial giant cell tumors (Table 5). Schwannoma
arising from unusual sites may superficially mimic inter-
digitating dendritic cell tumor. Both tumors are also posi-
tive for S-100 that may reinforce the misinterpretation.
However, absent or only few mitotic figures and a periph-
eral rim of lymphoid follicles with the usual formation of
germinal centers are key features for gastrointestinal
schwannomas (Fig. 5). Electron microscopy is also helpful:
complex interdigitating of cytoplasmic processes are char-
acteristic of interdigitating dendritic cell tumor, whereas
schwannoma typically shows long entangled thin cyto-
plasmic processes joined by rudimentary cell junctions and
coated by an external lamina on their free surface.34,44
Conclusion
Clinically meaningful diagnostic discrepancies occur
frequently during a hematopathology review. Non-
diagnostic or ambiguous original reports are the major
causative factor for the major discrepancy cases, which
demonstrates that diagnostic uncertainty and unfamiliarity
with the World Health Organization classification are major
problems for referral pathologists. Pathologically, the dif-
ferentiation of lymphoma from carcinoma and benign le-
sions from malignancy is critical. The common benign
mimickers, which have been misinterpreted as malig-
nancies, were lymphoid hyperplasia with secondary
changes, and lymphocytic panniculitis. By contrast, the
easily missed lymphomas were angioimmunoblastic T-cell
Hematopathology consultation 747lymphoma, DLBCL variants, lymphoplasmacytic lymphoma,
and the early stage of MALT lymphoma. The higher rate of
diagnostic divergence revealed here highlights the need for
access to hematopathology consultation. Pathologist edu-
cation programs should emphasize the discrepancies that
are most commonly encountered.45 Familiarity with easily
misinterpreted cases, which we outline here, helps to
achieve the right diagnosis and benefit patient care.Acknowledgments
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